Stock Markets April 20, 2026 10:31 AM

Topbuild, Kaspi.kz and a Range of Small- to Mid-Cap Stocks Lead Monday’s Market Moves

Deal announcements, upgrades and corporate transactions drove pronounced gains and losses across large-, mid- and small-cap names

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
BLD KSPI GFS OKTA MRVL

Stocks across market-cap segments recorded sharp moves on Monday as deal headlines, analyst upgrades and corporate disclosures influenced share prices. Topbuild surged after a $17 billion acquisition announcement, Kaspi.kz climbed, and a mix of technology, biotech and special-purpose acquisition companies logged both meaningful gains and declines. Several small-cap issues posted double-digit increases while other names dropped following share offerings or shareholder sales.

Topbuild, Kaspi.kz and a Range of Small- to Mid-Cap Stocks Lead Monday’s Market Moves
BLD KSPI GFS OKTA MRVL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Deal announcements and corporate actions drove large percentage moves in both large- and mid-cap stocks, including a $17 billion acquisition involving Topbuild Corp (BLD) and a $3.1 billion transaction tied to USA Rare Earth and Serra Verde (USAR).
  • Analyst upgrades underpinned gains in identity security and semiconductor-related names, notably Okta Inc (OKTA) after a Barclays upgrade and Marvell Technology Group Ltd (MRVL) after a GF Securities upgrade.
  • Capital markets activity such as share offerings and planned shareholder sales were linked to steep declines in certain small-cap issues, including Sidus Space (SIDU) and Pono Capital Two (SBC).

Monday’s trading session produced a series of sizable swings across the market-cap spectrum. News items ranging from a takeover proposal to analyst upgrades and capital-market transactions were associated with notable percentage moves in individual stocks.


Large-cap movers

Among large-cap listings, Topbuild Corp (BLD) led the group with a significant advance after an announcement that QXO will acquire TopBuild in a stock-and-cash transaction valued at $17 billion - the stock rose 16.14% on the day. Kaspi.kz AO ADR (KSPI) added 11.11%. Semiconductor and security-related names also moved higher: Globalfoundries (GFS) gained 7.8%, Okta Inc (OKTA) climbed 4.8% following a Barclays upgrade citing demand in identity security, and Marvell Technology Group Ltd (MRVL) rose 3.92% after GF Securities upgraded the stock on expectations of data center growth. Other large-cap swings included Vector Acquisition (RKLB) up 5.4% and Atlassian Corp Plc (TEAM) up 5.01%.

On the downside in this bracket, Silversun Tech (QXO) declined 8.1%, Talen Energy Corp (TLN) fell 4.37%, and New Providence Acquisition Corp N (ASTS) dropped 8.17%.


Mid-cap activity

Mid-cap names experienced pronounced volatility. Nektar Therapeutics (NKTR) jumped 18.28% after reporting extended alopecia areata trial results at 52 weeks. MaxLinear Inc (MXL) rose 13.73%. Inflection Point Acquisition II (USAR) was up 14.04% in conjunction with news that USA Rare Earth will acquire Serra Verde for $3.1 billion in cash and stock. Oaktree Acquisition Corp (HIMS) climbed 8.85%, Legend Biotech Corp (LEGN) added 9.47%, and Hertz Global Holdings NAQ (HTZ) gained 4.71%.

Meanwhile, several mid-cap issues moved lower: Babcock & Wilcox Enterprises (BW) fell 3.81%, Agios Pharmaceuticals (AGIO) dropped 21.93%, and Fermi America LLC (FRMI) slid 18.93%.


Small-cap leaders and decliners

Smaller-cap stocks recorded some of the day’s largest percentage gains. Compass Pathways Plc (CMPS) surged 36.79%, ATAI Life Sciences BV (ATAI) gained 27.67%, Aevex Inc (AVEX) rose 25.97%, GH Research (GHRS) advanced 25.03%, and POET Tech NAQ (POET) climbed 23.55%. Additional small-cap winners included Sila Realty Trust (SILA) up 18.92%, GoGreen Investments (LZM) up 17.76%, and Candel Therapeutics (CADL) up 11.93%.

Notable declines among smaller issues included Sidus Space (SIDU), which dropped 19.99% after pricing a $58.5 million stock offering at $4.35 per share, and Pono Capital Two (SBC), which fell 17.59% as a shareholder announced an intention to sell 3.1 million SBC Medical shares at $3.25 each.


Overall, Monday’s session highlighted how corporate actions - acquisitions, analyst upgrades and capital raises or planned share sales - continued to be primary drivers of intraday performance across market-cap tiers.

Risks

  • Market reactions to deal announcements and analyst actions can produce heightened volatility across sectors, affecting technology, industrials and acquisitions-related stocks.
  • Share offerings and announced secondary sales can lead to sharp downward pressure on small-cap issuers, posing liquidity and price risk for investors in those companies.
  • Clinical-trial updates and other binary biotech news can generate large single-day moves for mid-cap pharmaceutical and biotech stocks.

More from Stock Markets

Deutsche Bank: Investors Remain Cautious Even as Markets Hold Tight Ranges Sep 19, 2026 Adobe and Intuit Compared: Valuation, Profitability, and Street Conviction Sep 18, 2026 Large Domino’s options block centers on bullish calendar spreads at $460 and $480 strikes Sep 18, 2026 Strive Shares Advance as Bitcoin-Treasury Stocks Rebound After Fed Decision Sep 18, 2026 Barclays launches bullish coverage of Hill & Smith, citing U.S. grid and data-center demand Sep 18, 2026